Prevention of chlamydia-induced infertility by inhibition of local caspase activity

Journal of Infectious Diseases

Volumn 207, Issue 7, 2013, Pages 1095-1104

  Igietseme, Joseph U ^a,b   Omosun, Yusuf ^a,b   Partin, James ^a   Goldstein, Jason ^a   He, Qing ^a,b   Joseph, Kahaliah ^a   Ellerson, Debra ^a   Ansari, Uzma ^a   Eko, Francis O ^b   Bandea, Claudiu ^a   Zhong, Guangming ^c   Black, Carolyn M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

caspase; Chlamydia; Dicer; infertility and pathogenesis; inflammasome; miRNAs

Indexed keywords

BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; DICER; INTERLEUKIN 1BETA CONVERTING ENZYME; MICRORNA; MICRORNA 21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FEMALE INFERTILITY; GENE MUTATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN TARGETING; SEROTYPE; TISSUE INJURY; TUBAL FACTOR INFERTILITY;

ANIMALS; APOPTOSIS; CASPASE 1; CASPASE 3; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENZYME ACTIVATION; FEMALE; HELA CELLS; HUMANS; INFERTILITY, FEMALE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84874672505     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit009     Document Type: Article

References (48)

1. Detels R, Green A, Klausner J, et al. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis 2011; 38:503-9.
2. Healy D, Trounson A, Andersen A. Female infertility: causes and treatment Lancet 1994; 343:1539-44. (Pubitemid 24180053)
3. Ison C. Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment. Curr Opin Infect Dis 2012; 25:73-8.
4. Soper D. Pelvic inflammatory disease. Obstet Gynecol 2010; 116:419-28.
5. Darville T, O'Niell JM, Andrews CW Jr, Nagarajan UM, Ojcius DM. Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003; 171:6187-97. (Pubitemid 37467242)
6. Cheng W, Shivshankar P, Li Z, Chen L, Yeh I, Zhong G. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 2008; 76:515-22. (Pubitemid 351251721)
7. Li Z, Chen D, Zhong Y, Wang S, Zhong G. The chlamydial plasmidencoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun 2008; 76:3415-28.
8. Buchholz K, Stephens R. The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection. Infect Immun 2008; 76:3150-5.
9. Abdul-Sater A, Said-Sadier N, Ojcius DM, Yilmaz O, Kelly KA. Inflammasomes bridge signaling between pathogen identification and the immune response. Drugs Today 2009; 45:105-12.
10. Murthy A, Li W, Chaganty B, et al. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun 2011; 79:2928-35.
11. Wynn T. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208:1339-50.
12. Melloul D. Role of NF-κB in β-cell death. Biochem Soc Trans 2008; 36:334-9.
13. Dixon R, Hwang S, Hennig G, et al. Chlamydia infection causes loss of pacemaker cells and inhibits oocyte transport in the mouse oviduct. Biol Reprod 2009; 80:665-73.
14. O'Connell C, Ingalls R, Andrews CJ, Scurlock A, Darville T. Plasmiddeficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 2007; 179:4027-34.
15. Olivares-Zavaleta N, Whitmire W, Gardner D, Caldwell H. Immunization with the attenuated plasmidless Chlamydia trachomatis L2 (25667R) strain provides partial protection in a murine model of female genitourinary tract infection. Vaccine 2009; 28:1454-62.
16. Kari L, Whitmire W, Olivares-Zavaleta N, et al. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med 2011; 208:2217-23.
17. Shao R. Understanding the mechanisms of human tubal ectopic pregnancies: new evidence from knockout mouse models. Hum Reprod 2010; 25:584-7.
18. Williams A. Functional aspects of animal microRNAs. Cell Mol Life Sc 2008; 65:545-62. (Pubitemid 351297689)
19. Luense L, Carletti M, Christenson L. Role of Dicer in female fertility. Trends Endocrinol Metab 2009; 20:265-72.
20. Nagaraja A, Andreu-Vieyra C, Franco H, et al. Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol 2008; 22:2336-52.
21. Carletti M, Christenson L. MicroRNA in the ovary and female reproductive tract. J Anim Sci 2009; 87:E29-38.
22. Su A, Cooke M, Ching K, et al. Large-scale analysis of the human and mouse transcriptomes. PNAS USA 2002; 99:4465-70. (Pubitemid 34286008)
23. Bhat-Nakshatri P, Wang G, Collins N, et al. Estradiol-regulated micro- RNAs control estradiol response in breast cancer cells. Nucleic Acids Research 2009; 37:4850-61.
24. Tang F, Kaneda M, O'Carroll D, et al. Maternal microRNAs are essential for mouse zygotic development. Genes Dev 2007; 21:644-8. (Pubitemid 46440286)
25. Matskevich A, Moelling K. Stimuli-dependent cleavage of Dicer during apoptosis. Biochem J 2008; 412:527-34. (Pubitemid 351846418)
26. Ghodgaonkar M, Shah R, Kandan-Kulangara F, et al. Abrogation of DNA vector-based RNAi during apoptosis in mammalian cells due to caspase-mediated cleavage and inactivation of Dicer-1. Cell Death Differ 2009; 16:858-68.
27. Peterson EM, Markoff BA, Schachter J, de la Maza LM. The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism. Plasmid 1990; 23:144-8. (Pubitemid 20202913)
28. Igietseme J, He Q, Joseph K, et al. Role of T lymphocytes in the pathogenesis of Chlamydia disease. J Infect Dis 2009; 200:926-34.
29. Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Let 1981; 12:111-5. (Pubitemid 12243441)
30. Tuffrey M, Alexander F, Woods C, Taylor-Robinson D. Genetic susceptibility to chlamydial salpingitis and subsequent infertility in mice. J Reprod Fertil 1992; 95:31-8.
31. Pal S, Hui W, Peterson EM, de la Maza LM. Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital infection. J Med Microbiol 1998; 47:599-605. (Pubitemid 28313948)
32. Muppidi J, Porter M, Siegel R. Measurement of apoptosis and other forms of cell death. Curr Protoc Immunol 2004; 3:Unit 3.17.
33. Chang C, Zhang Q, Liu Z, Clynes R, Suciu-Foca N, Vlad G. Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. J Immunol 2012; 188:3042-52.
34. Rank RG. Animal models of urogenital infections. Methods Enzymol 1994; 235:83-93.
35. Johansson M, Schon K, Ward M, Lycke N. Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for human? Scand J Immunol 1997; 46:546-52. (Pubitemid 28035414)
36. Prantner D, Darville T, Sikes J, et al. Critical role for interleukin-1beta (IL-1β) during Chlamydia muridarum genital infection and bacterial replication-independent secretion of IL-1β in mouse macrophages. Infect Immun 2009; 77:5334-46.
37. Zhong G. Chlamydia trachomatis secretion of proteases for manipulating host signaling pathways. Front Microbiol 2011; 2:14.
38. Ying S, Pettengill M, Ojcius D, Häcker G. Host-cell survival and death during Chlamydia infection. Curr Immunol Rev 2007; 3:31-40. (Pubitemid 46605109)
39. Emamaullee J, Davis J, Pawlick R, et al. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes 2008; 57: 1556-66.
40. Dixon R, Ramsey K, Schripsema J, Sanders K, Ward S. Time-dependent disruption of oviduct pacemaker cells by Chlamydia infection in mice. Biol Reprod 2010; 83:2244-253.
41. Dixon R, Hennig G, Baker S, et al. Electrical slow waves in the mouse oviduct are dependent upon a calcium activated chloride conductance encoded by Tmem16a. Biol Reprod 2012; 86:1-7.
42. Gomez-Pinilla P, Gibbons S, Bardsley M, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1370-81.
43. Bonci D. MicroRNA-21 as therapeutic target in cancer and cardiovascular disease. Recent Pat Cardiovasc Drug Discov 2010; 5:156-61.
44. Vitiello D, Kodaman P, Taylor H. HOX genes in implantation. Semin Reprod Med 2007; 25:431-6. (Pubitemid 350058429)
45. Miller J. The Wnts. Genome Biol 2002; 3:3001.1-15.
46. Mellman I, Clausen B. B-Catenin balances immunity. Science 2010; 329:767-9.
47. Harfe B, McManus M, Mansfield J, Hornstein E, Tabin C. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci U S A 2005; 102:10898-903. (Pubitemid 41105964)
48. Nakagawa A, Shi Y, Kage-Nakadai E, Mitani S, Xue D. Caspasedependent conversion of dicer ribonuclease into a death-promoting deoxyribonuclease. Science 2010; 328:327-34.